A systematic review of adherence with medications for diabetes.
By J. Cramer. Diabetes Care, 2004
879 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Family Practice
View Paper: https://www.semanticscholar.org/paper/60ee9f924ecf2b79c414c6041a9908c96fda7c2c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- L. García‐Pérez
- Vicente Francisco Gil-Guillén
- Domingo Orozco-Beltrán
- R. Epstein
- R. Verbrugge
- K. McGuigan
- L. Monnier
- T. Dilla
In Family Practice
- L. García‐Pérez
- Vicente Francisco Gil-Guillén
- Domingo Orozco-Beltrán
- R. Epstein
- R. Verbrugge
- K. McGuigan
- T. Dilla
- M. Sokol
Citations in the corpus
- Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost (2005, result): “Adherence rates in this study were typical of the rates often reported for chronic conditions.(15,16,34,38) Observed adherence rates (defined as the proportion of patients with 80–100% adherence) ranged between 55% and 73% for the 4 conditions in this study.”
- Adherence to Therapies in Patients with Type 2 Diabetes (2013, methodology): “Nevertheless, in an analysis of 11 retrospective studies between 1966 and 2003, adherence (defined in some of the studies as taking 90% of medication) to OHA therapy ranged from 36% to 93% in patients remaining on treatment for 6–24 months [24].”
- Self-report measures of medication adherence behavior: recommendations on optimal use (2015, background): “Inadequate adherence to medications is unfortunately widespread across ages, health conditions, and medication regimens [10, 25–27].”
- Diabetes 2030: Insights from Yesterday, Today, and Future Trends (2017, neutral): “Several studies have shown poor adherence to medication regimens among patients with type 1 and type 2 diabetes.(30) A 2014 study by Li et al found that during 2011– 2012 only 6.”
- An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives. (2005, background): “Such data indicate clearly that the patient’s objectives are different from those of their health care providers [4].”